Bvl Clinical Research

BVL Clinical Research is a dedicated clinical research site located in the Midwest, specializing in studies in the fields of gastroenterology. Our goal is to advance medical care and improve patient outcomes by evaluating the safety and effectiveness of innovative treatments through high-quality clinical research. Our Principal Investigator, Dr. Christopher Bartalos, is a board-certified gastroenterologist with over 25 years of experience in treating inflammatory bowel disease (IBD). Under his leadership, we are proud to bring cutting-edge clinical studies to the Kansas City Metro’s Crohn’s disease and ulcerative colitis communities. We offer access to the latest investigational therapies that are completely voluntary and at no cost to qualified participants. Currently, our research focuses on multiple clinical trials for Crohn’s Disease and Ulcerative Colitis, contributing to the development of new therapies for these chronic gastrointestinal conditions. Through our commitment to scientific excellence, patient-centered care, and collaborative innovation, BVL Clinical Research plays a vital role in advancing treatments that enhance quality of life for patients everywhere.